Treatment cost assessment for COVID-19 inpatients in Shenzhen, China 2020-2021: facts and suggestions.
Frontiers in public health（2023）
Abstract
Our findings identified the difference of inpatient treatment cost across seven COVID-19 clinical classifications and the changes at three admission stages. It is highly suggestive to inform the financial burden experienced by the health insurance fund and the Government, to emphasize the rational use of lab tests and western medicine in the COVID-19 treatment guideline, and to design suitable treatment and control policy for convalescent cases.
MoreTranslated text
Key words
COVID-19,inpatient treatment cost,cost components,clinical classification,China
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined